Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs INCY✓SelectedUSD · INCYGSK vs INCY performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs INCY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
INCY return
+77.5%
Excess return
-36.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioINCYExcessAlpha
1D-0.1%-1.1%+0.9%+0.1%
7D-5.3%-5.2%-0.1%-4.1%
30D-3.7%+1.0%-4.7%-3.9%
3M-7.3%-9.9%+2.6%-5.1%
6M-4.2%+18.1%-22.3%-7.6%
YTD+0.9%+16.1%-15.2%-2.6%
1Y+7.3%+12.6%-5.4%+4.0%
3Y+52.7%+109.5%-56.8%+27.5%
All+41.1%+77.5%-36.4%+24.9%

Cumulative growth

Daily Returns

Daily percentage return beside INCY.

Daily Out/Under-Performance

Portfolio return minus INCY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × INCY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded INCY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling